Orthopedic Devices Market

Orthopedic Devices Market worth $48.1 billion by 2028

The report "Orthopedic Devices Market by Product (Fixation, Replacement Devices {knee, Hip, Shoulder}, Braces, Spinal Implants, Arthroscopy, Orthobiolgics), Application (Fracture Treatment, Osteoarthritis), End User (Hospital, ASCs)- Global Forecast to 2028" is projected to reach USD 48.1 billion by 2028 from USD 36.3 billion in 2022, at a CAGR of 4.8% during the forecast period. Growth in elderly population worldwide, increasing number of osteoarthritis cases, growing participation in sports, rising awareness about the presence of orthopedic treatment, technological advancements and growth strategies adopted by the players in the orthopedic devices such as product launches, agreements, partnerships, and acquisitions are expected to propel the growth of the market.

Browse 278 market data Tables and 41 Figures spread through 386 Pages and in-depth TOC on "Orthopedic Devices Market - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/orthopedic-device-280.html

The orthopedic devices market includes major Tier I and II suppliers of orthopedic products are Stryker Corporation (US), Johnson & Johnson (US), Smith & Nephew (UK), Medtronic plc (Ireland), Zimmer Biomet (US), B. Braun (Germany), Enovis (US), NuVasive (US), Acumed LLC (US), BSN Medical (Germany), CONMED Corporation (US), Orthofix Medical Inc. (US), Arthrex (US), Allegra Orthopaedics (Australia), DeRoyal Industries (US), MicroPort (China), Nippon Sigmax Co., Ltd. (Japan), TriMed Inc. (US), Altis Biologics (South Africa), Isto Biologics (US), ITS (Austria), Meril Life Sciences Pvt. Ltd. (India), Mueller Sports Medicine, Inc. (US), RCH Orthopaedics (India), and FLA Orthopedics (US).

Increasing aging population with degenerative spine diseases are anticipated to accelerate the demand for spinal implants and surgical devices

The incidence of degenerative lumbar spine disease is currently increasing among older generation and this has led to an increased demand for spinal surgeries. Acceptance of minimally invasive procedures in treatment of spinal cord disorders involve lesser muscle damage, blood loss, shorter hospital stays; quicker recovery; and preservation of spinal mobility post-surgery are contributing towards the growth of the segment. Moreover, rising cases of road accidents and sports related spinal injuries and growing advancements in spinal implants are anticipated to enhance the growth of segment.

Orthopedic devices market is anticipated to grow at the fastest pace in Asia Pacific

The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028. The presence of a large patient population, improved healthcare infrastructure, the rising number of hospitals, and the rapidly growing aging population (especially in Japan and China) are likely to contribute towards the rapid growth of orthopedic devices market in Asia Pacific Additionally, grants offered by the government to promote the awareness and research on orthopedic diseases, expansion of geographical footprints of key players in Asian Countries by setting up orthopedic devices manufacturing units and increasing local manufacturers in the region are anticipated to support the significant growth orthopedic devices market in Asia Pacific.

Prominent players in this market are Stryker Corporation (US), Johnson & Johnson (US), Smith & Nephew (UK), Medtronic plc (Ireland), Zimmer Biomet (US), B. Braun (Germany), Enovis (US), NuVasive (US), Acumed LLC (US), BSN Medical (Germany), CONMED Corporation (US), Orthofix Medical Inc. (US), Arthrex (US), Allegra Orthopaedics (Australia), DeRoyal Industries (US), among others

Don’t miss out on business opportunities in Orthopedic Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Orthopedic Devices Market Size,  Share & Growth Report
Report Code
MD 1304
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Orthopedic Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status

Digital Virtual Assistant - MarketsandMarkets